"Pituitary adenoma; endocrinology; radiosurgery; endoscopy; intraoperative magnetic resonance imaging"@en . . "L\u00E9\u010Dba adenom\u016F hypof\u00FDzy" . "CZ - \u010Cesk\u00E1 republika" . "L\u00E9\u010Dba adenom\u016F hypof\u00FDzy"@cs . "3" . . "Pituitary Adenoma Therapy"@en . . . "3"^^ . "209149" . "Pituitary adenomas constitute 10-15% of intracranial tumours. These lesions are benign in the vast majority of cases. A combination of medical, neurosurgical and radiosurgical means is applied in treating them. A %22%22watch-and-wait%22%22 strategy is also a legitimate approach to treatment in certain cases. Only an appropriate combination of these modalities yields the best possible outcome. Close collaboration between endocrinologist, neurosurgeon and radiosurgeon is therefore essential. The endoscopic technique of pituitary adenoma resection is among the newer developments in surgical treatment, and intra-operative MR facilitates improved surgical results. This leads us to believe that intra-operative MR is indicated in surgery of sellar lesions. The goal of treatment is pituitary adenoma control, enabling the patient to live a normal life, of normal life expectancy, without hormonal substitution (whenever possible) and without visual impairment."@en . . . . "Masopust, V\u00E1clav" . "3"^^ . . "1210-7859" . "\u010Cesk\u00E1 a slovensk\u00E1 Neurologie neurochirurgie" . . "V" . . "74/107" . "Adenomy hypof\u00FDzy tvo\u0159\u00ED 10-15 % intrakrani\u00E1ln\u00EDch n\u00E1dor\u016F. V naprost\u00E9 v\u011Bt\u0161in\u011B p\u0159\u00EDpad\u016F se jedn\u00E1 o l\u00E9ze nezhoubn\u00E9. P\u0159i l\u00E9\u010Db\u011B t\u011Bchto l\u00E9z\u00ED se kombinuj\u00ED farmakologick\u00E9, neurochirurgick\u00E9 a radiochirurgick\u00E9 postupy. Vzhledem k benign\u00EDmu charakteru adenom\u016F hypof\u00FDzy je observace ve vybran\u00FDch p\u0159\u00EDpadech zcela legitimn\u00ED l\u00E9\u010Debn\u00E1 modalita. Jedin\u011B spr\u00E1vn\u00E1 kombinace t\u011Bchto postup\u016F p\u0159in\u00E1\u0161\u00ED nejlep\u0161\u00ED mo\u017En\u00E9 v\u00FDsledky u pacient\u016F s adenomy hypof\u00FDzy. Proto je zcela nezbytn\u00E1 mezioborov\u00E1 spolupr\u00E1ce endokrinologa, neurochirurga a radiochirurga. Mezi novinky v neurochirurgick\u00E9 oblasti l\u00E9\u010Dby pacient\u016F s adenomy hypof\u00FDzy pat\u0159\u00ED zaveden\u00ED endoskopick\u00FDch technik. Mo\u017Enost intraopera\u010Dn\u00ED MR p\u0159in\u00E1\u0161\u00ED zlep\u0161en\u00ED opera\u010Dn\u00EDch v\u00FDsledk\u016F, a proto pova\u017Eujeme jej\u00ED pou\u017Eit\u00ED u operac\u00ED sel\u00E1rn\u00EDch l\u00E9z\u00ED za indikovan\u00E9. C\u00EDlem l\u00E9\u010Dby adenom\u016F hypof\u00FDzy je takov\u00E1 kontrola n\u00E1doru, aby nemocn\u00FD \u017Eil sv\u016Fj norm\u00E1ln\u00ED \u017Eivot norm\u00E1ln\u00ED d\u00E9lky, pokud mo\u017Eno bez nutnosti hormon\u00E1ln\u00ED substituce a bez poruchy zraku." . . "14"^^ . . . . "Adenomy hypof\u00FDzy tvo\u0159\u00ED 10-15 % intrakrani\u00E1ln\u00EDch n\u00E1dor\u016F. V naprost\u00E9 v\u011Bt\u0161in\u011B p\u0159\u00EDpad\u016F se jedn\u00E1 o l\u00E9ze nezhoubn\u00E9. P\u0159i l\u00E9\u010Db\u011B t\u011Bchto l\u00E9z\u00ED se kombinuj\u00ED farmakologick\u00E9, neurochirurgick\u00E9 a radiochirurgick\u00E9 postupy. Vzhledem k benign\u00EDmu charakteru adenom\u016F hypof\u00FDzy je observace ve vybran\u00FDch p\u0159\u00EDpadech zcela legitimn\u00ED l\u00E9\u010Debn\u00E1 modalita. Jedin\u011B spr\u00E1vn\u00E1 kombinace t\u011Bchto postup\u016F p\u0159in\u00E1\u0161\u00ED nejlep\u0161\u00ED mo\u017En\u00E9 v\u00FDsledky u pacient\u016F s adenomy hypof\u00FDzy. Proto je zcela nezbytn\u00E1 mezioborov\u00E1 spolupr\u00E1ce endokrinologa, neurochirurga a radiochirurga. Mezi novinky v neurochirurgick\u00E9 oblasti l\u00E9\u010Dby pacient\u016F s adenomy hypof\u00FDzy pat\u0159\u00ED zaveden\u00ED endoskopick\u00FDch technik. Mo\u017Enost intraopera\u010Dn\u00ED MR p\u0159in\u00E1\u0161\u00ED zlep\u0161en\u00ED opera\u010Dn\u00EDch v\u00FDsledk\u016F, a proto pova\u017Eujeme jej\u00ED pou\u017Eit\u00ED u operac\u00ED sel\u00E1rn\u00EDch l\u00E9z\u00ED za indikovan\u00E9. C\u00EDlem l\u00E9\u010Dby adenom\u016F hypof\u00FDzy je takov\u00E1 kontrola n\u00E1doru, aby nemocn\u00FD \u017Eil sv\u016Fj norm\u00E1ln\u00ED \u017Eivot norm\u00E1ln\u00ED d\u00E9lky, pokud mo\u017Eno bez nutnosti hormon\u00E1ln\u00ED substituce a bez poruchy zraku."@cs . . . "Netuka, David" . "L\u00E9\u010Dba adenom\u016F hypof\u00FDzy" . . . "Pituitary Adenoma Therapy"@en . . "[D1DE52227BEF]" . "Bene\u0161, Vladim\u00EDr" . "L\u00E9\u010Dba adenom\u016F hypof\u00FDzy"@cs . "RIV/61383082:_____/11:0013!RIV12-MO0-61383082" . "RIV/61383082:_____/11:0013" .